Rain Oncology Inc (RAIN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAIN | OSTX | ACHL | ||
| Company | Rain Oncology Inc | Os Therapies Incorporated | Achilles Therapeutics Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 1.2400 | 2.50 | 1.0500 | ||
| High | 1.2700 | 2.50 | 1.0800 | ||
| Low | 1.2100 | 2.10 | 1.0200 | ||
| Last | 1.2100 | 2.20 | 1.0500 | ||
| Change | -0.0200 | unch | -0.0200 | ||
| % Change | -1.63% | unch | -1.87% | ||
| Volume | 3,706,000 | 22,400 | 320,800 | ||
| 20-Day Average Volume | 524,660 | 19,645 | 142,515 | ||
| Previous Close | 1.2300 | 2.20 | 1.0700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.2095 | 2.71 | 1.0181 | ||
| 20-Day Raw Stochastic | 29.41% | 9.71% | 61.11% | ||
| 20-Day Relative Strength | 55.65% | 34.51% | 60.67% | ||
| Weighted Alpha | -5.00 | N/A | +17.78 | ||
| Today's Opinion | 40% Buy | N/A | 88% Buy | ||
| Previous Opinion | 40% Buy | N/A | 88% Buy | ||
| Last Month's Opinion | 24% Buy | N/A | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.83% since 01/18/24 | -22.81% since 11/08/24 | unch since 11/08/24 | ||
| Low | 1.2000 on 01/19/24 | 2.10 on 11/15/24 | 0.9901 on 11/13/24 | ||
| High | 1.2700 on 01/25/24 | 2.88 on 11/11/24 | 1.1200 on 11/14/24 | ||
| 1-Month | |||||
| %Chg | unch since 12/22/23 | -27.11% since 10/15/24 | +6.60% since 10/15/24 | ||
| Low | 1.1850 on 01/02/24 | 2.10 on 11/15/24 | 0.9400 on 10/22/24 | ||
| High | 1.2700 on 01/25/24 | 3.15 on 10/17/24 | 1.1200 on 11/14/24 | ||
| 3-Month | |||||
| %Chg | +14.15% since 10/25/23 | -37.85% since 08/15/24 | +41.89% since 08/15/24 | ||
| Low | 0.9900 on 11/29/23 | 2.10 on 11/15/24 | 0.6300 on 08/28/24 | ||
| High | 1.2700 on 01/25/24 | 4.47 on 08/26/24 | 1.1200 on 11/14/24 | ||
| 6-Month | |||||
| %Chg | -9.02% since 07/25/23 | N/A since 08/01/24 | +14.13% since 05/15/24 | ||
| Low | 0.8200 on 10/03/23 | 2.10 on 11/15/24 | 0.6300 on 08/28/24 | ||
| High | 1.3899 on 07/27/23 | 4.90 on 08/02/24 | 1.1200 on 11/14/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 44,015 | 44,110 | 43,964 | ||
| Shares Outstanding, K | 36,376 | 20,050 | 41,088 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -75,720,000 | -7,790,000 | -69,670,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -7,030,000 | -1,560,000 | -16,380,000 | ||
| 60-Month Beta | 0.27 | N/A | 1.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 11/09/23 | -0.26 on 08/14/24 | -0.41 on 08/14/24 | ||
| Latest Earnings Date | 03/14/24 | 11/13/24 | 11/18/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||